Welcome to our dedicated page for Axcelis Technologies news (Ticker: ACLS), a resource for investors and traders seeking the latest updates and insights on Axcelis Technologies stock.
Axcelis Technologies Inc. (Nasdaq: ACLS) is a world-leading provider of equipment and services to the semiconductor manufacturing industry. For over 35 years, Axcelis has been a trusted partner for chipmakers globally, delivering cutting-edge solutions and expertise in the critical process of ion implantation. This process is essential for the fabrication of semiconductor chips used in everyday electronics such as smartphones, laptops, cameras, and more.
The company's suite of products includes advanced ion implantation systems, which form transistors that power electronic devices. Axcelis' Purion™ platform is renowned for its flexibility and advanced technology, catering to diverse needs from high current to high energy implants. The Purion Power Series™, particularly, addresses the growing demand in power device applications, including silicon carbide (SiC) technology, crucial for automotive, industrial, and energy applications.
Axcelis also offers comprehensive aftermarket services, including spare parts, equipment upgrades, maintenance, and customer training, ensuring maximum operational efficiency and longevity of its products. The company’s advanced technology center in Beverly, Mass., serves as a hub for innovation, collaborating with industry experts and customers to develop next-generation applications.
Financially robust, Axcelis continues to achieve record performance. In 2023, the company reported a 23% year-over-year growth, with revenues surpassing $1.1 billion. The strong market position is further evidenced by a $1.2 billion backlog at the year's end. Axcelis' strategic focus on the Asia Pacific region, which contributes significantly to its revenue, underscores its global outreach and market adaptability.
Recent achievements highlight Axcelis' leadership and innovation. The company showcased its latest technologies at SEMICON Korea 2024 and announced multiple shipments of its Purion Power Series™ to leading chipmakers worldwide. Axcelis also strengthened its board with new directors, bringing in valuable industry expertise.
As the semiconductor industry evolves, Axcelis remains committed to driving innovation and supporting its customers with state-of-the-art ion implantation solutions, ensuring a bright and technologically advanced future.
Axcelis Technologies, Inc. (NASDAQ: ACLS) announced significant shipments of its Purion Power Series™ ion implanter systems to silicon carbide (SiC) power device manufacturers across Asia, Europe, and the U.S. These advanced systems, including the Purion H200™, Purion XE™, and Purion M™, support high-volume production for electric vehicle applications. The company forecasts that power device shipments will account for 35% to 40% of total system shipments in 2022, with further growth anticipated in 2023. CEO Mary Puma noted the rapid growth in the SiC power device market, driven by the shift toward electric vehicles.
Axcelis Technologies (Nasdaq: ACLS) will announce its 2022 financial results on February 8, 2023, at 4:00 PM ET. A subsequent conference call to discuss these results will take place on February 9, 2023, at 8:30 AM ET. Investors can access the call via an audio webcast on the company's website. Axcelis has been a key player in providing high-productivity solutions for the semiconductor industry for over 40 years, focusing on ion implantation systems, which are critical in integrated circuit manufacturing.
Axcelis Technologies reported strong financial guidance for Q4 2022, anticipating revenue exceeding $250 million, surpassing previous estimates of $232-$240 million. For the full year 2022, revenue is expected to exceed $900 million, with earnings per diluted share anticipated to be over $1.45 in Q4 and exceed $5.00 for the full year. CEO Mary Puma emphasized robust customer demand for the Purion product family, hinting at year-over-year growth in 2023, supported by favorable foreign exchange impacts on earnings.
Axcelis Technologies (Nasdaq: ACLS) announced its participation in the 25th Annual Needham Growth Conference, scheduled for January 10-11, 2023, at the Lotte New York Palace Hotel and virtually on January 12, 2023. The company will present on January 11th at 2:15 p.m. EST, with management available for one-on-one meetings. A live webcast will be accessible from Axcelis' website, with a replay available for 30 days after the event. Axcelis has been a key player in the semiconductor industry for over 40 years, focusing on ion implantation systems.
Axcelis Technologies (Nasdaq: ACLS) announced multiple shipments of the Purion Dragon™ high current implanter, including a follow-on order and a new customer evaluation aimed at semiconductor manufacturers in Asia. These shipments are part of Q4 2022 activities and support advanced memory and logic device development. Executive VP Greg Redinbo emphasized the Purion Dragon's capabilities, highlighting its advanced process control and productivity gains for high current applications. This move reinforces Axcelis' commitment to innovation in the semiconductor industry.
Axcelis Technologies (Nasdaq: ACLS) will showcase its innovative Purion and GSD Ovation Series ion implanters at SEMICON Japan 2022, held from December 14-16 in Tokyo. The event aims to highlight technologies that support power device, image sensor, memory, and logic markets. Key products include the Purion Power Series for silicon processing and the Purion XE Series with Boost Technology for advanced image sensors. Axcelis aims to expand its market share in Japan by meeting the increasing demand from chipmakers with these advanced solutions.
Axcelis Technologies (NASDAQ: ACLS) will participate in the 11th Annual NYC Summit on December 13, 2022, in New York City. The event features small group meetings between investors and company management teams. Presentation materials will be accessible on Axcelis' investor page. The NYC Summit is invitation-only for accredited investors and research analysts, with RSVP required by December 1, 2022. Axcelis has a strong track record in providing ion implantation solutions for the semiconductor industry, serving the market for over 40 years.
On Nov. 17, 2022, Axcelis Technologies (Nasdaq: ACLS) announced its founding membership in the Semiconductor Climate Consortium (SCC), aimed at combating climate change within the semiconductor industry. President and CEO Mary Puma emphasized this membership enhances Axcelis' sustainability efforts through collaboration. The SCC focuses on pooling industry resources to tackle decarbonization challenges and sets collective sustainability goals. Axcelis has over 40 years of experience in providing innovative ion implantation solutions critical to integrated circuit manufacturing.
On November 10, 2022, Axcelis Technologies (Nasdaq: ACLS) announced significant new shipments of its Purion Power Series ion implanter systems to various fabs in Asia and Europe. This includes the first SiC tool shipped from their South Korea operations. Key models shipped are the Purion H200, Purion XE, and Purion M, aimed at high-volume production of Si and SiC power devices. CEO Mary Puma highlighted continued growth in the power device market and emphasized the company's technological advantages and market share prospects.
FAQ
What is the current stock price of Axcelis Technologies (ACLS)?
What is the market cap of Axcelis Technologies (ACLS)?
What does Axcelis Technologies Inc. specialize in?
What are the key products of Axcelis Technologies?
How does Axcelis support its products post-sale?
Where is Axcelis Technologies headquartered?
What financial achievements did Axcelis report for 2023?
What is the significance of the Purion Power Series™?
How does Axcelis collaborate with the semiconductor industry?
What recent strategic moves has Axcelis made?
What upcoming events is Axcelis participating in?
What is the future outlook for Axcelis Technologies?
